Spyre Therapeutics, Inc. (SYRE) — EPS (Diluted)

Annual figures by fiscal year, from SEC filings.

2020: $-1.522021: $-25.022022: $-24.862023: $13.76$13.76
2020EPS (Diluted) (USD/shares)2023
Fiscal YearEPS (Diluted)Change YoY
2023$13.76+155.3%
2022$-24.86+0.6%
2021$-25.02-1546.1%
2020$-1.52